跳至主要内容
临床试验/NCT02307344
NCT02307344Unknown不适用

Effect of Nigella Sativa on Nonalcoholic Steatohepatitis and Steatosis

Hillel Yaffe Medical Center1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2015年1月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
100
试验地点
1
主要终点
Effect of Nigella Sativa on Liver Triglyceride Concentration

研究概览

简要总结

The investigators hypothesize that Nigella Sativa will have an effect on Nonalcoholic Steatohepatitis and Liver Steatosis by enhancing lipophagy in the liver tissue.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Patients suffering from Steatohepatitis
  • •Patients suffering from Liver Steatosis

排除标准

  • •Patients suffering from viral hepatitis
  • •Patients with HIV infection
  • •Patients suffering from Wilsons Disease

研究组 & 干预措施

Patients receiving a placebo tablet

Active Comparator

Twenty patients suffering from Nonalcoholic Steatohepatitis or Liver Steatosis will ingest placebo capsules twice a day, that look like the capsules of those receiving the Nigella Sativa.

干预措施: Placebo (Dietary Supplement)

Nigella Sativa Supplement

Active Comparator

Fifty patients suffering from Nonalcoholic Steatohepatitis or Liver Steatosis will ingest capsules containing 2 grams of Nigella Sativa divided into 1 grams twice a day.

干预措施: Nigella Sativa (Dietary Supplement)

结局指标

主要结局

Effect of Nigella Sativa on Liver Triglyceride Concentration

时间窗: One year

The difference in change in the average liver triglyceride concentration will be measured by MRI Spectroscopy between the Nigella Sativa arm and the placebo arm, at start and end of the study.

次要结局

  • Effect of Nigella Sativa on Improvement in NASH Activity Index(One year)
  • Effect of Nigella Sativa on Fibrosis Staging(One year)

研究者

申办方类型
Other Gov
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验